Total Payments
$448,963
2024 Payments
$1,498
Companies
37
Transactions
1,164
Medicare Patients
592
Medicare Billing
$237,678
Payment Breakdown by Category
Other$398,221 (88.7%)
Food & Beverage$22,644 (5.0%)
Travel$21,992 (4.9%)
Consulting$6,000 (1.3%)
Education$103.97 (0.0%)
Gifts$2.51 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $398,221 | 209 | 88.7% |
| Food and Beverage | $22,644 | 874 | 5.0% |
| Travel and Lodging | $21,992 | 73 | 4.9% |
| Consulting Fee | $6,000 | 1 | 1.3% |
| Education | $103.97 | 6 | 0.0% |
| Gift | $2.51 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $235,731 | 236 | $0 (2024) |
| Allergan, Inc. | $144,766 | 308 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $37,704 | 135 | $0 (2024) |
| ABBVIE INC. | $22,142 | 63 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,701 | 30 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,098 | 69 | $0 (2020) |
| Lundbeck LLC | $973.86 | 64 | $0 (2024) |
| Neos Therapeutics, LP | $782.27 | 15 | $0 (2024) |
| ITI, Inc. | $712.59 | 29 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $641.67 | 43 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,498 | 22 | Janssen Pharmaceuticals, Inc ($1,221) |
| 2023 | $672.04 | 30 | Axsome Therapeutics, Inc. ($177.30) |
| 2022 | $3,276 | 50 | ABBVIE INC. ($2,410) |
| 2021 | $48,212 | 103 | Alkermes, Inc. ($25,220) |
| 2020 | $43,252 | 126 | Alkermes, Inc. ($31,338) |
| 2019 | $139,125 | 281 | Alkermes, Inc. ($84,294) |
| 2018 | $138,808 | 346 | Allergan Inc. ($73,366) |
| 2017 | $74,120 | 206 | Alkermes, Inc. ($37,847) |
All Payment Transactions
1,164 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: ADHD | ||||||
| 12/02/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: CNS | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/08/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $16.36 | General |
| 10/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $643.30 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $273.00 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $119.32 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 09/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: PSYCHIATRY | ||||||
| 08/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/25/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CNS | ||||||
| 04/16/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $15.47 | General |
| 03/25/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 02/21/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Neuroscience | ||||||
| 01/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: PSYCHIATRY | ||||||
| 01/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Insomnia | ||||||
| 12/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Central Nervous System | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 119 | 263 | $63,740 | $31,737 |
| 2022 | 3 | 67 | 130 | $22,989 | $9,876 |
| 2021 | 4 | 139 | 720 | $157,156 | $74,026 |
| 2020 | 8 | 267 | 1,295 | $248,888 | $122,039 |
Total Patients
592
Total Services
2,408
Medicare Billing
$237,678
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 32 | 133 | $30,058 | $15,058 | 50.1% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 17 | 55 | $14,960 | $7,315 | 48.9% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 32 | 32 | $8,544 | $4,251 | 49.8% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2023 | 14 | 15 | $4,425 | $2,165 | 48.9% |
| 90869 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent motor threshold redetermination with delivery and management | Office | 2023 | 12 | 13 | $3,458 | $1,801 | 52.1% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 12 | 15 | $2,295 | $1,146 | 49.9% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 11 | 32 | $8,704 | $4,644 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 47 | $8,930 | $3,101 | 34.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 28 | 51 | $5,355 | $2,131 | 39.8% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 17 | 357 | $106,011 | $52,047 | 49.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 156 | $29,927 | $11,843 | 39.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 51 | 175 | $16,635 | $8,360 | 50.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 32 | $4,583 | $1,776 | 38.8% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), per session | Office | 2020 | 27 | 540 | $161,900 | $72,300 | 44.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 268 | $33,500 | $20,016 | 59.7% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 61 | 315 | $23,625 | $16,716 | 70.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 44 | 71 | $8,213 | $3,880 | 47.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 29 | 30 | $9,500 | $3,323 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 45 | $4,500 | $2,304 | 51.2% |
| 90867 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression) | Office | 2020 | 14 | 14 | $5,250 | $1,982 | 37.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,400 | $1,517 | 63.2% |
About Dr. Amit Mohan, MD
Dr. Amit Mohan, MD is a Psychiatry healthcare provider based in Beachwood, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1821219841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Mohan, MD has received a total of $448,963 in payments from pharmaceutical and medical device companies, with $1,498 received in 2024. These payments were reported across 1,164 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($398,221).
As a Medicare-enrolled provider, Mohan has provided services to 592 Medicare beneficiaries, totaling 2,408 services with total Medicare billing of $237,678. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Beachwood, OH
- Active Since 05/01/2007
- Last Updated 09/14/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1821219841
Products in Payments
- VRAYLAR (Drug) $166,606
- ARISTADA (Drug) $134,070
- Aristada 441 mg (Drug) $94,735
- ABILIFY MAINTENA (Drug) $26,722
- REXULTI (Drug) $11,809
- LYBALVI (Drug) $6,906
- SPRAVATO (Drug) $1,605
- LATUDA (Drug) $1,098
- Adzenys XR-ODT (Drug) $782.27
- CAPLYTA (Drug) $759.26
- AUSTEDO (Drug) $625.80
- Xyrem (Drug) $272.97
- Trintellix (Drug) $238.52
- VYVANSE (Drug) $209.92
- VIIBRYD (Drug) $200.00
- TRINTELLIX (Drug) $197.96
- Auvelity (Drug) $177.30
- XYWAV (Drug) $170.99
- INGREZZA (Drug) $154.86
- XYREM (Drug) $128.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Beachwood
Boris Royak, Md, MD
Psychiatry — Payments: $67,614
Psychiatry $67,614
Stephen Levine, Md, MD
Psychiatry — Payments: $7,579
Psychiatry $7,579
Larissa Elgudin, Md, MD
Psychiatry — Payments: $6,032
Psychiatry $6,032
Dr. Brooke Wolf, M.d, M.D
Psychiatry — Payments: $4,116
Psychiatry $4,116
Dr. Gary Wilkes, M.d, M.D
Psychiatry — Payments: $2,473
Psychiatry $2,473
Dr. Carol Macknin, M.d, M.D
Psychiatry — Payments: $2,336
Psychiatry $2,336